Selected article for: "accumulation synthesis and lymph node"

Author: Fu, Yu; Lee, Inhan; Lee, Yong Sun; Bao, Xiaoyong
Title: Small Non-coding Transfer RNA-Derived RNA Fragments (tRFs): Their Biogenesis, Function and Implication in Human Diseases
  • Document date: 2015_12_31
  • ID: 0b08jyjs_20
    Snippet: One of the tRF-1 series (namely tRF-1001), derived from pre-tRNA Ser , is highly expressed in several cancer cell lines relative to non-proliferating normal tissues, and is required for proliferation of prostate cancer cells [3] . The levels of tRF-1001 in cancer cells are directly related to the degree of cellular proliferation. Knocking down this tRF causes a dramatic loss of cell viability and inhibition of cell proliferation with specific acc.....
    Document: One of the tRF-1 series (namely tRF-1001), derived from pre-tRNA Ser , is highly expressed in several cancer cell lines relative to non-proliferating normal tissues, and is required for proliferation of prostate cancer cells [3] . The levels of tRF-1001 in cancer cells are directly related to the degree of cellular proliferation. Knocking down this tRF causes a dramatic loss of cell viability and inhibition of cell proliferation with specific accumulation of cells in G2 phase and inhibition of DNA synthesis [3] . In addition, analysis of the small RNA transcriptome in prostate cancer revealed enrichment of tRFs in both non-metastatic and metastatic lymph node prostate cancer samples [3] . The molecular mechanism by which tRF-1001 affects cell physiology is not known. There may be a differential processing of tRNA in prostate cancer because tRFs in non-metastatic samples were 18 nucleotides long whereas tRFs in metastatic tissues were 27 nucleotides long [49] .

    Search related documents:
    Co phrase search for related documents
    • cancer cell and cell line: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cancer cell and cell physiology: 1, 2, 3, 4
    • cancer cell and cell proliferation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cancer cell and cell proliferation inhibition: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • cancer cell and cell viability: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cancer cell and cellular proliferation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • cancer cell and dna synthesis: 1
    • cancer cell and metastatic tissue: 1, 2
    • cancer cell level and cell line: 1
    • cancer cell level and cell proliferation: 1, 2, 3
    • cancer cell level and cell viability: 1, 2, 3
    • cancer sample and cell line: 1
    • cell line and dna synthesis: 1, 2, 3
    • cell proliferation and differential processing: 1
    • cell proliferation and dna synthesis: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • cell viability and dna synthesis: 1, 2
    • cellular proliferation and dna synthesis: 1, 2